Search details
1.
Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer.
Gastroenterology
; 159(1): 306-319.e12, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32179091
2.
Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
Hum Mol Genet
; 25(23): 5148-5166, 2016 12 01.
Article
in English
| MEDLINE | ID: mdl-27677309
3.
Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
Hum Mol Genet
; 25(22): 4881-4897, 2016 11 15.
Article
in English
| MEDLINE | ID: mdl-28173111
4.
Crystal Structures of the Human Doublecortin C- and N-terminal Domains in Complex with Specific Antibodies.
J Biol Chem
; 291(31): 16292-306, 2016 07 29.
Article
in English
| MEDLINE | ID: mdl-27226599
5.
Salinization and arsenic contamination of surface water in southwest Bangladesh.
Geochem Trans
; 18(1): 4, 2017 Sep 11.
Article
in English
| MEDLINE | ID: mdl-29086805
6.
Mitigation of reactive metabolite formation for a series of 3-amino-2-pyridone inhibitors of Bruton's tyrosine kinase (BTK).
Bioorg Med Chem Lett
; 27(3): 632-635, 2017 02 01.
Article
in English
| MEDLINE | ID: mdl-28025004
7.
Use of Artificial Intelligence and Machine Learning Algorithms with Gene Expression Profiling to Predict Recurrent Nonmuscle Invasive Urothelial Carcinoma of the Bladder.
J Urol
; 195(2): 493-8, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26459038
8.
Sources of salinity and arsenic in groundwater in southwest Bangladesh.
Geochem Trans
; 17: 4, 2016.
Article
in English
| MEDLINE | ID: mdl-27403083
9.
Drinking water insecurity: water quality and access in coastal south-western Bangladesh.
Int J Environ Health Res
; 26(5-6): 508-24, 2016.
Article
in English
| MEDLINE | ID: mdl-27277537
10.
Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization.
Proc Natl Acad Sci U S A
; 109(29): 11788-93, 2012 Jul 17.
Article
in English
| MEDLINE | ID: mdl-22745160
11.
Generation and external validation of a tumor-derived 5-gene prognostic signature for recurrence of lymph node-negative, invasive colorectal carcinoma.
Cancer
; 118(21): 5234-44, 2012 Nov 01.
Article
in English
| MEDLINE | ID: mdl-22605513
12.
Antitumor activity and pharmacokinetic properties of PF-00299804, a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor.
Mol Cancer Ther
; 7(7): 1880-9, 2008 Jul.
Article
in English
| MEDLINE | ID: mdl-18606718
13.
Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells.
Mol Cancer Ther
; 5(5): 1299-308, 2006 May.
Article
in English
| MEDLINE | ID: mdl-16731763
14.
Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptors.
J Med Chem
; 49(4): 1475-85, 2006 Feb 23.
Article
in English
| MEDLINE | ID: mdl-16480284
15.
The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer.
BMC Cancer
; 6: 159, 2006 Jun 16.
Article
in English
| MEDLINE | ID: mdl-16780590
16.
Utilizing peptide structures as keys for unlocking challenging targets.
Mini Rev Med Chem
; 6(9): 979-87, 2006 Sep.
Article
in English
| MEDLINE | ID: mdl-17017997
17.
Targeting protein-protein interactions for cancer therapy.
J Mol Med (Berl)
; 83(12): 955-63, 2005 Dec.
Article
in English
| MEDLINE | ID: mdl-16283145
18.
Plasma vascular endothelial growth factor and interleukin-8 as biomarkers of antitumor efficacy of a prototypical erbB family tyrosine kinase inhibitor.
Mol Cancer Ther
; 4(6): 938-47, 2005 Jun.
Article
in English
| MEDLINE | ID: mdl-15956251
19.
Differential sensitivity of cancer cells to inhibitors of the epidermal growth factor receptor family.
Oncogene
; 21(1): 119-27, 2002 Jan 03.
Article
in English
| MEDLINE | ID: mdl-11791182
20.
Development of E3-substrate (MDM2-p53)-binding inhibitors: structural aspects.
Methods Enzymol
; 399: 622-33, 2005.
Article
in English
| MEDLINE | ID: mdl-16338385